Daniel Camardo
Director/Board Member at CommunityHealth NFP
Net worth: 1 141 $ as of 2024-04-29
Daniel Camardo active positions
| Companies | Position | Start | End |
|---|---|---|---|
| CommunityHealth NFP | Director/Board Member | - | - |
Career history of Daniel Camardo
Former positions of Daniel Camardo
| Companies | Position | Start | End |
|---|---|---|---|
| ATHERSYS, INC. | Comptroller/Controller/Auditor | 2022-07-01 | 2023-12-30 |
| Director/Board Member | 2022-02-13 | 2023-12-30 | |
| Chief Executive Officer | 2022-02-13 | 2023-12-30 | |
| Director of Finance/CFO | 2022-07-01 | - | |
| Corporate Secretary | 2022-02-13 | 2023-12-30 | |
| HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY | Corporate Officer/Principal | 2015-08-31 | 2022-01-31 |
Clarus Therapeutics, Inc.
 Clarus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Clarus Therapeutics, Inc. operated as a men's health specialty pharmaceutical company that focuses on the development and commercialization of oral testosterone replacement therapy. It offered JATENZO, a soft gel oral formulation of testosterone undecanoate for treating hypogonadal men. The company was founded by Robert E. Dudley in February 2004 and was headquartered in Northbrook, IL. | Sales & Marketing | 2014-06-30 | 2015-08-31 |
Astellas Pharma US, Inc.
 Astellas Pharma US, Inc. Pharmaceuticals: MajorHealth Technology Astellas Pharma US, Inc. manufactures pharmaceutical products. It offers cardiology, dermatology, immunology, infectious diseases, and urology. The firm was founded in 2005 and is headquartered in Northbrook, IL. | Corporate Officer/Principal | 2002-12-31 | 2003-12-31 |
Training of Daniel Camardo
| Rochester Christian University | Undergraduate Degree |
| Kellogg School of Management | Masters Business Admin |
Statistics
International
| United States | 7 |
| Ireland | 2 |
Operational
| Corporate Officer/Principal | 2 |
| Director/Board Member | 2 |
| Comptroller/Controller/Auditor | 1 |
Sectoral
| Health Technology | 5 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| ATHERSYS, INC. | Health Technology |
| Private companies | 4 |
|---|---|
Horizon Therapeutics Plc
 Horizon Therapeutics Plc Pharmaceuticals: MajorHealth Technology Horizon Therapeutics Plc is a biopharmaceutical company, which engages in the research, development, and marketing of pharmaceutical products. It operates through the Orphan and Inflammation segments. The Orphan segment consists of medicines KRYSTEXXA, RAVICTI, PROCYSBI, ACTIMMUNE, BUPHENYL, QUINSAIR, and RAYOS. The Inflammation segment comprises medicines PENNSAID 2%, DUEXIS, and VIMOVO. The company was founded in 2008 and is headquartered in Dublin, Ireland. | Health Technology |
Clarus Therapeutics, Inc.
Clarus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Clarus Therapeutics, Inc. operated as a men's health specialty pharmaceutical company that focuses on the development and commercialization of oral testosterone replacement therapy. It offered JATENZO, a soft gel oral formulation of testosterone undecanoate for treating hypogonadal men. The company was founded by Robert E. Dudley in February 2004 and was headquartered in Northbrook, IL. | Health Technology |
Astellas Pharma US, Inc.
Astellas Pharma US, Inc. Pharmaceuticals: MajorHealth Technology Astellas Pharma US, Inc. manufactures pharmaceutical products. It offers cardiology, dermatology, immunology, infectious diseases, and urology. The firm was founded in 2005 and is headquartered in Northbrook, IL. | Health Technology |
| CommunityHealth NFP |
- Stock Market
- Insiders
- Daniel Camardo
- Experience